AHIMA 2024: Showcasing Top Coding Vendors & HIM Innovations From Black Book Research Annual Industry Survey

AHIMA 2024, taking place this week in Salt Lake City, brings together industry leaders to showcase groundbreaking AI innovations reshaping health information management (HIM). The event highlights advancements in coding, data analytics, and patient care, with vendors unveiling AI-powered solutions to streamline workflows, enhance accuracy, and improve healthcare outcomes. Additionally, Black Book announces the top-rated AHIMA-sponsoring vendors for 2024, based on highest customer experience.

SALT LAKE CITY, UT / ACCESSWIRE / October 27, 2024 / The American Health Information Management Association (AHIMA) 2024 Conference, taking place October 27-29 at the Salt Palace Convention Center, promises to be a key event for health information management professionals. This year’s exhibit hall will feature 17 top-rated vendors recognized by Black Book Research, known for its rigorous and independent vendor ranking process. Black Book surveyed over 4,000 industry professionals to evaluate providers in coding and health information management, assessing critical factors like quality, reliability, innovation, interoperability, and user experience.

Black Book ensures accuracy by incorporating only verified responses, delivering a comprehensive view of the highest-performing vendors in the industry. AHIMA 2024 attendees can benefit from hands-on interactions with these vendors, gaining firsthand insights into tools that enhance data management, security, and analytics.

The exhibit hall presents a valuable chance to connect with the 2024 top-rated vendors and explore solutions that drive efficiency, accuracy, and compliance in healthcare data management. Below is a list of the leading AHIMA showcasing vendors, each bringing forward the latest advancements to support organizations in staying ahead of today’s rapidly evolving healthcare landscape.

Mid RCM/Front End-to-Back End Enterprise HIM Software Solutions: IODINE SOFTWARE (Booth 712)

Outsourced Coding Services: IKS HEALTH (Booth1410)

Clinical Documentation Improvement Software: DOLBEY SYSTEMS (Booth 1102)

Automated Document Imaging, Abstracting and Indexing: 314E (Booth 1105)

Release of Information Management Software: VERISMA (Booth 702)

Autonomous Coding/NLP/ML Solutions: CODAMETRIX (Booth 624)

Enterprise Data Archiving and Migration: OLAH HEALTHCARE TECHNOLOGY (Booth 807)

ICD-10 Coding & Chart Review Services: OPTUM (Booth 1518)

HIM Advisory and CDI Consultant Firm: E4HEALTH (Booth 1002)

Medical Coding Flexible Staffing Firms: KIWI-TEK (Booth 1402)

Clinical Surveillance and Compliance Applications: WOLTERS KLUWER (Booth 1123)

Advanced HIM Data Analytics & Data Asset Management Solutions: DATAVANT (Booth 1209)

Virtual Scribes, Medical Transcription & Document Capture: IKS HEALTH (Booth 1410)

Generative AI /GPT Architecture for Medical Coding: AKASA (Booth 723)

End-to-End RCM Outsourcing, Community Hospitals: CONIFER HEALTH (Booth 1329)

End-to-End RCM Outsourcing, Hospital Chains & IDNs: R1 (Booth 1333)

End-to-End RCM Software, Community Hospitals: TRUBRIDGE (Booth 618)

HIM Workforce Augmentation: OXFORD GLOBAL RESOURCES (Booth 917)

About Black Book

Black Book Research stands apart in the healthcare IT analysis sector by providing unbiased, data-driven insights without financial ties to vendors. Black Book does not solicit or accept commissioned research, ensuring the integrity of its findings. Its rankings and reports are based solely on user feedback, offering transparent evaluations that empower buyers to make truly informed decisions. This commitment to impartiality and transparency protects providers, payers, and ancillary organizations from misleading research influenced by vendor funding.

Contact Information

Press Office
research@blackbookmarketresearch.com
8008637590

SOURCE: Black Book Research

View the original press release on newswire.com.

Staff

Recent Posts

Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024

Data confirm the use of FFRCT and Plaque Analysis helps assess long-term risks, informing more…

14 hours ago

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024

The detailed study results confirmed interim findings, showing stable kidney function and sustained treatment effect…

14 hours ago

Novartis oral Fabhalta® (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial 

New APPEAR-C3G data show Fabhalta sustained proteinuria reduction at 12 months1Upon Fabhalta initiation, improvement observed…

14 hours ago

Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

Long-term improvements observed in the quartet of findings defining disease modification supports atacicept’s potential to…

14 hours ago

Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria

First to demonstrate clinical benefit in patients with chronic inducible urticaria (CIndU) in large, randomized, placebo-controlled…

14 hours ago